IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $148,000 | +5.7% | 15,488 | +22.1% | 0.01% | +28.6% |
| Q2 2022 | $140,000 | -52.1% | 12,685 | -27.7% | 0.01% | -56.2% |
| Q1 2022 | $292,000 | -2.7% | 17,538 | +11.7% | 0.02% | +45.5% |
| Q4 2021 | $300,000 | +6.8% | 15,700 | +37.6% | 0.01% | -26.7% |
| Q3 2021 | $281,000 | -31.1% | 11,413 | -11.5% | 0.02% | -34.8% |
| Q1 2021 | $408,000 | -27.3% | 12,900 | +6.6% | 0.02% | -51.1% |
| Q4 2020 | $561,000 | +55.0% | 12,100 | +10.0% | 0.05% | +20.5% |
| Q3 2020 | $362,000 | +27.5% | 11,000 | +15.8% | 0.04% | +14.7% |
| Q1 2020 | $284,000 | +30.3% | 9,500 | -20.8% | 0.03% | +161.5% |
| Q3 2019 | $218,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |